Evidence map›Paper›PMID 40458125›Full record

ArticleJournal of AIDS and HIV treatment2025

The Performance of a New Multidimensional Frailty Index in Comparison to the Frailty Phenotype to Assess Frailty in People Living with HIV 50 Years of Age and Older in an Urban HIV Clinic.

Uzoamaka A Eke, Katie Wasserstein, Carolyn Susman, Ahizechukwu C Eke, Kareshma Mohanty, Sarah Schmalzle, Nicole Viviano, Jennifer D Hoffmann, Neha S Pandit, Robyn Palmeiro and 4 more

Abstract read
In one paragraph

Article in Journal of AIDS and HIV treatment, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Uzoamaka A EkeDivision of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Maryland, USA.
Katie WassersteinPenn State College of Medicine, Pennsylvania, USA.
Carolyn SusmanPerelman School of Medicine, University of Pennsylvania, Pennsylvania, USA.
Ahizechukwu C EkeJohns Hopkins School of Medicine, Maryland, USA.
Kareshma MohantyUniversity of Maryland Baltimore, Maryland, USA.
Sarah SchmalzleDivision of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Maryland, USA.
Nicole VivianoUniversity of Maryland Baltimore, Maryland, USA.
Jennifer D HoffmannDivision of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Maryland, USA.
Neha S PanditUniversity of Maryland School of Pharmacy, Maryland, USA.
Robyn PalmeiroDivision of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Maryland, USA.
Judith LeeDivision of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Maryland, USA.
Alice S RyanBaltimore Geriatric Research, Education, and Clinical Center (GRECC), The Veterans Affairs Maryland Health Care System, Maryland, USA.
Kristen A StaffordCenter for International Health, Education, and Biosecurity (CIHEB), Institute of Human Virology, University of Maryland School of Medicine, Maryland, USA.
Ann Gruber-BaldiniDepartment of Epidemiology and Public Health, University of Maryland School of Medicine, Maryland, USA.

Funding

University of Maryland Claude D. Pepper Older Americans Independence Center (UM-OAIC)P30AG028747 · NIA · UNIVERSITY OF MARYLAND BALTIMORE · PI ALICE S. RYAN · 2006 to 2026
$28.9M
Integrated proteomic and metabolomic biomarker profiling for understanding metabolic syndrome in pregnant women living with HIV on Tenofovir Disoproxil Fumarate/Lamivudine/Dolutegravir (TLD)DP1HD115433 · NICHD · JOHNS HOPKINS UNIVERSITY · PI AHIZECHUKWU C. EKE · 2024 to 2026
$1.7M
Understanding Medication Adherence Benchmarks, Safety and Pharmacometrics of Novel Antiretrovirals in Pregnant Women Living with HIV.K23HD104517 · NICHD · JOHNS HOPKINS UNIVERSITY · PI EKE, AHIZECHUKWU C. · 2020 to 2024
$857k
NIA NIH HHS P30 AG028747NICHD NIH HHS DP1 HD115433NICHD NIH HHS K23 HD104517RRD VA IK6 RX003977
6 · The paper itself

Abstract

Background: Frailty is increasingly recognized in older people living with HIV (PLWH), but optimal diagnostics are yet to be determined. Frailty indices (FI) represent an accumulation of health deficits shown to correlate better with mortality and adverse effects of aging than the frailty phenotype or chronological age. Methods: This is a retrospective cohort study of frailty assessments in PLWH aged ≥ 50 years in a multidisciplinary urban HIV clinic. Frailty was assessed using Frailty Phenotype (FP) and a new 40-variable clinical composite FI derived from routine clinical and laboratory data (CCFI). CCFI scores were categorized into robust (≤ 0.15), pre-frail (>0.15-0.4), and frail (>0.4). CCFI frailty and its association with frailty-related factors were analyzed using logistic regression. Results: The 165 participants were mostly black (94%) and male (56%), with median age 59 years (IQR 55-63), CD4 count 606 cells/μl (IQR 393-873), and 78% had HIV viral load ≤ 40 copies/ml. 70% had multimorbidity, 38% falls, 25% poor cognition, and 24% polypharmacy. By FP, 2% were frail, 65% prefrail, and 33% robust. By CCFI, 26% were frail, 67% prefrail, and 7% robust (range 0.08-0.57; mean 0.34 ±0.11). For FP categorized as robust, prefrail and frail, the mean CCFI was 0.31 ± 0.1, 0.35 ± 0.11 and 0.38 ± 0.08 respectively (P=0.06). Cognition (OR 3.64, p=0.003), falls (OR 5.09, p<0.001), polypharmacy of 6-9 medications (OR 3.07, p=0.03) and ≥ 10 medications (OR 4.25, p=0.009) and >3 comorbidities (OR 3.06, p=0.03) were associated with CCFI frailty, adjusted for age and sex. Conclusion: The majority of older PLWH were pre-frail or frail. The CCFI identified more patients as frail and had significant clinical associations compared to FP.

Indexed as

AIDSFrailtyFrailty and HIVFrailty assessmentsFrailty indexHIV and Aging

Identifiers

PMID40458125
PMCPMC12129442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.